Drug resistance analysis of staphylococcus infection in our hospital from 2003 to 2005.
- Author:
Shui-guo DU
1
;
Yu LIN
;
Xiao-dong WANG
;
Li WU
Author Information
- Publication Type:Journal Article
- MeSH: Anti-Bacterial Agents; pharmacology; Cross Infection; microbiology; Drug Resistance, Multiple, Bacterial; Humans; Reconstructive Surgical Procedures; Staphylococcal Infections; microbiology; Staphylococcus; drug effects; isolation & purification
- From: Chinese Journal of Plastic Surgery 2006;22(3):207-209
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the change in mobility of staphylococcus and its drug resistance etiology investigation and clinical treatment.
METHODSThe routine biochemical identification was used for staphylococcus differentiation. Minimal inhibitory concentrations was used for drug-resistance determination. Some drug-resistance determination were detected by K-B method. The inducible resistance of erythromycin to clindamycin was checked by D-test.
RESULTSStaphylococcus was in the first place in the hospital infection. The rates of methicillin-resistant staphylococcus were 54.1%. The drug-resistance rates of staphylococcus to penicillin, oxacillin, erythromycin, tetracycline, ciprofloxacin, gentamicin, clindamycin, SMZCO, chloramphenicol, vancomycin, teicoplanin antibacterials were 93.2%, 54.1%, 85.1%, 56.7%, 45.9%, 48.6%, 58.1%. 45.9%, 31.1%, 0%, 0%. D-test positive rate was 37.9%.
CONCLUSIONSThe results are helpful in study of pathogenic bacteria and drug resistance characteristics in staphylococcus infection.
